JAK1 and neoplasm: JAK1 mRNA expression was significantly downregulated in both endometrial tumor samples and endometrial cell lines with a JAK1 frameshift compared to JAK1 wildtype endometrial samples (Fig 1G and 1H, tumor: P < 10−18, cell line: P < 10−4, Mann-Whitney U test).